SA
Sign upLog In

Novo Nordisk A/S Common Stock (NVO)

Cost of Revenue

kr 63.75B

TTM · Period ending: · DKK

NVO logo

NVO Cost of Revenue

Latest reportedkr 63.75B DKK
NVO TTM Cost of Revenue · DKK (kr 0.00 → kr 63.75B)
High-resolution chart · PNG

NVO cost of revenue history

Trailing twelve months (TTM) · DKK. Each value covers four complete reported quarters.

Novo Nordisk A/S Common Stock Cost of Revenue — Trailing twelve months (TTM) (DKK)
Period endingCost of Revenue (DKK)
63,750,000,000
59,496,000,000
58,788,000,000
56,664,000,000
50,068,000,000
47,496,000,000
44,522,000,000
41,512,000,000
39,917,000,000
37,499,000,000
35,765,000,000
34,013,000,000
31,500,000,000
29,713,000,000
28,448,000,000
26,427,000,000
25,286,000,000
24,764,000,000
23,658,000,000
23,036,000,000
22,132,000,000
21,357,000,000
20,932,000,000
20,745,000,000
20,665,000,000
20,742,000,000
20,088,000,000
19,309,000,000
18,649,000,000
18,152,000,000
17,617,000,000
17,664,000,000
17,521,000,000
17,578,000,000
17,632,000,000
17,850,000,000
17,564,000,000
17,200,000,000
17,183,000,000
16,873,000,000
16,734,000,000
16,548,000,000
16,188,000,000
15,579,000,000
15,158,000,000
14,970,000,000
14,562,000,000
13,963,000,000
14,062,000,000
13,997,000,000
14,140,000,000
13,893,000,000
13,853,000,000
13,671,000,000
13,465,000,000
13,434,000,000
13,200,000,000
12,875,000,000
12,589,000,000
12,552,000,000
12,237,000,000
12,107,000,000
11,680,000,000
11,230,000,000
10,979,000,000
10,620,000,000
10,438,000,000
10,367,330,000
10,288,330,000
10,232,813,000
10,137,813,000
10,184,812,300
10,091,123,300
9,896,505,300
9,805,193,300
9,777,458,000
9,606,187,000
9,499,636,000
9,591,159,000
9,523,829,000
9,539,967,000
9,489,946,000
9,163,009,000
8,875,569,000
8,606,943,000
8,347,473,000
8,097,964,000
5,869,140,000
3,780,588,000
1,836,765,000
0
0
0
0
0
0
0
0
0
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.